MedTrace Logo

Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR

NCT01759121 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2017-10-13

No results posted yet for this study

Summary

This randomized, parallel controlled, clinical-trial aims to evaluate the therapeutic efficacy of 532nm laser partially subthreshold panretinal photocoagulation with PASCAL endpoint management function for severe non-proliferative diabetic retinopathy.

Conditions

  • Severe Non-proliferative Diabetic Retinopathy

Interventions

RADIATION

T-PRP

532nm-short pulse panretinal photocoagulation with PASCAL function

RADIATION

S-PRP

532nm-partially subthreshold short pulse panretinal photocoagulation with PASCAL endpoint management function

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Chen-jin Jin · Zhongshan Ophthalmic Center, Sun Yat-sen University

  • Pei-pei Wu · Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01759121 on ClinicalTrials.gov